Maher Masoud is the President and Chief Executive Officer of MaxCyte, Inc., a leading provider of cell engineering and cell therapy solutions. Prior to his current role, Masoud served as the Executive Vice President at MaxCyte, where he played a pivotal role in shaping the company's strategic direction and growth. With an extensive background in the life sciences industry, Masoud has been instrumental in driving MaxCyte's mission to advance the development of life-saving cell therapies. Before joining MaxCyte, Masoud held various leadership positions at renowned life sciences companies, where he gained valuable experience in product development, commercialization, and corporate strategy. His expertise in the field has been crucial in positioning MaxCyte as a trusted partner for biopharmaceutical companies and academic institutions worldwide. Under his leadership, MaxCyte has successfully expanded its portfolio of cell engineering platforms and established collaborations with leading players in the cell therapy space. As President and CEO, Maher Masoud continues to steer MaxCyte towards its goal of revolutionizing the cell therapy landscape. His strategic vision and commitment to innovation have enabled the company to make significant strides in the development of next-generation cell therapies. Masoud's leadership has been instrumental in fostering a culture of collaboration and excellence within MaxCyte, positioning the company for continued success in the rapidly evolving field of cell engineering and therapy.